Welcome to our dedicated page for Waldencast news (Ticker: WALD), a resource for investors and traders seeking the latest updates and insights on Waldencast stock.
Waldencast plc operates as a global multi-brand beauty and wellness platform built around Obagi Medical and Milk Makeup. News about WALD commonly covers brand-level product launches, physician-dispensed skincare, cosmetics, suncare, and aesthetic offerings, including Obagi's advanced skincare products and Obagi® saypha® MagIQ™ hyaluronic acid filler.
Company updates also include quarterly and annual financial results, segment performance, channel and distribution developments, clinical-evidence collaborations for aesthetic products, supply-chain and credit-facility actions, and governance or reporting matters tied to financial restatements, internal control over financial reporting, and regulatory review.
Waldencast Acquisition Corp. (NASDAQ: WALD) has announced that CEO Michel Brousset will participate in investor meetings and a fireside chat at the D.A. Davidson 5th Annual Consumer Growth Conference on March 10, 2022. Waldencast will also join Evercore ISI CPG Growth Day on March 22, 2022. The discussions aim to promote Waldencast's vision of building a best-in-class beauty and wellness operating platform through partnerships with purpose-driven brands like Obagi and Milk Makeup. Key financial documents regarding these proposed transactions have been filed with the SEC.
Waldencast Acquisition Corp. (NASDAQ: WALD) has announced a definitive business combination with Obagi and Milk Makeup, valued at approximately $1.2 billion. The merger aims to establish a global beauty platform focused on high-growth, purpose-driven brands. The transaction will be funded through a combination of IPO cash, Forward Purchase Agreements, and rollover equity. Waldencast's leadership will include industry veterans, with the goal of driving growth and shareholder value. The merger is expected to close in the first half of 2022, pending shareholder approval.
Waldencast Acquisition Corp. (NASDAQ: WALD) received a notice from Nasdaq on May 28, 2021, for failing to timely file its Quarterly Report on Form 10-Q for the quarter ending March 31, 2021. This non-compliance with Nasdaq Listing Rule 5250(c)(1) does not immediately affect its securities listing, which will continue to trade on Nasdaq. WALD has 60 days to file the Form 10-Q or submit a compliance plan. If accepted, Nasdaq may grant up to 180 days for compliance, until November 22, 2021. The Company is also evaluating the accounting treatment of its warrants under recent SEC guidance.
Summary not available.